About Teadus Pharma Private Limited
Data last updated:
Teadus Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 January 2023.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2023PTC170281. Its GSTIN is 36AAJCT9153D1Z5 (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Umamaheswar Siripurapu and Manikreddy Pullagurla.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 50 Ravi Enclave Kondapur Serlingampally, Hyderabad, Telangana, India – 500084.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.7 Cr. For the same year it recorded a net profit of ₹17.82 Lakh (net margin 1%) and EBITDA of ₹1 Cr (EBITDA margin 5.4%).
The company has about 96 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹20.36 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website teaduspharma.com.
Company details
Contact details
Teadus Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is teaduspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No 50 Ravi Enclave Kondapur Serlingampally, Hyderabad, Telangana, India – 500084
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Teadus Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Teadus Pharma is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Teadus Pharma Private Limited, buy the company report.
Financials of Teadus Pharma Private Limited
FY 2024 filings availableTeadus Pharma Private Limited reported revenue of ₹18.7 Cr for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹18.7 Cr | |
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹1 Cr | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹17.82 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.4% | |
| Net Profit Margin | 1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Teadus Pharma Private Limited, buy the company report.
Board of directors of Teadus Pharma Private Limited
Teadus Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manikreddy Pullagurla Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Biolyx Lifesciences Private Limited and 5 more | Additional Director | 12 Mar 2025 | 1 Years 7 Months | Current |
| Umamaheswar Siripurapu Also directs: Energon Labs Private Limited | Director | 10 Jan 2023 | 3 Years 9 Months | Current |
| Jagadeesh Babu Rangisetty Also directs: Leiutis Pharmaceuticals LLP, Ewings Ventures LLP, Envozyme Feeds Private Limited and 5 more | Additional Director | 12 Mar 2025 | 1 Years 7 Months | Current |
Auditor
Teadus Pharma Private Limited is audited by VSPN AND CO CHARTERED ACCOUNTANTS for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VSPN AND CO CHARTERED ACCOUNTANTS | FY 2024 | 0008178S |
Shareholding
The shareholding of Teadus Pharma Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Teadus Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2023 | 100704652 | Hdfc Bank Limited | ₹20.36 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Teadus Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Teadus Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Teadus Pharma Private Limited has a workforce of 96 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
GST
Teadus Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCT9153D1Z5 | Telangana | Active | 22 Feb 2023 |
To see the full GST registrations and return filing status of Teadus Pharma Private Limited, buy the company report.
Recent activity
Teadus Pharma Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Selvakumar Balaraman ceased to be Director on 31 Jul 2025.
Frequently asked questions
Teadus Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 January 2023 (3+ years old) and is registered under CIN U24230TG2023PTC170281.
Teadus Pharma has 3 current directors:
- Manikreddy Pullagurla - Additional Director
- Umamaheswar Siripurapu - Director
- Jagadeesh Babu Rangisetty - Additional Director
The latest financial statements of Teadus Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Teadus Pharma is 36AAJCT9153D1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Teadus Pharma is U24230TG2023PTC170281. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Teadus Pharma was incorporated on 10 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Hyderabad.
Selvakumar Balaraman ceased to be Director on 31 Jul 2025. Jagadeesh Babu Rangisetty was appointed as Additional Director on 12 Mar 2025. Manikreddy Pullagurla was appointed as Additional Director on 12 Mar 2025. Teadus Pharma has 4 board changes on record in total.
Teadus Pharma can be reached through the website teaduspharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Teadus Pharma is at Plot No 50 Ravi Enclave Kondapur Serlingampally, Hyderabad, Telangana, India – 500084.
Teadus Pharma operates in the pharma industry, in the drug formulation and development segment.